Walgreens Boots Alliance, Inc. (WBA) Stake Held by Douglass Winthrop Advisors LLC

Douglass Winthrop Advisors LLC maintained its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the third quarter, Holdings Channel reports. The firm owned 45,805 shares of the pharmacy operator’s stock at the end of the third quarter. Douglass Winthrop Advisors LLC’s holdings in Walgreens Boots Alliance were worth $3,693,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of WBA. BlackRock Institutional Trust Company N.A. boosted its stake in shares of Walgreens Boots Alliance by 0.7% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 22,365,047 shares of the pharmacy operator’s stock valued at $1,862,337,000 after buying an additional 159,480 shares during the last quarter. Capital World Investors boosted its stake in Walgreens Boots Alliance by 11.5% in the second quarter. Capital World Investors now owns 19,625,115 shares of the pharmacy operator’s stock worth $1,634,183,000 after buying an additional 2,028,252 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in Walgreens Boots Alliance by 7.2% in the second quarter. Bank of New York Mellon Corp now owns 13,003,529 shares of the pharmacy operator’s stock worth $1,082,804,000 after buying an additional 874,011 shares during the last quarter. BlackRock Fund Advisors boosted its stake in Walgreens Boots Alliance by 3.3% in the third quarter. BlackRock Fund Advisors now owns 10,356,853 shares of the pharmacy operator’s stock worth $834,969,000 after buying an additional 331,571 shares during the last quarter. Finally, BlackRock Group LTD boosted its stake in Walgreens Boots Alliance by 2.5% in the third quarter. BlackRock Group LTD now owns 7,560,651 shares of the pharmacy operator’s stock worth $609,541,000 after buying an additional 182,237 shares during the last quarter. Institutional investors and hedge funds own 60.15% of the company’s stock.

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 83.31 on Friday. The stock has a market capitalization of $89.93 billion, a P/E ratio of 22.05 and a beta of 1.20. Walgreens Boots Alliance, Inc. has a 1-year low of $75.74 and a 1-year high of $88.00. The stock has a 50 day moving average of $82.55 and a 200 day moving average of $82.16.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, January 5th. The pharmacy operator reported $1.10 EPS for the quarter, beating the consensus estimate of $1.09 by $0.01. Walgreens Boots Alliance had a net margin of 3.52% and a return on equity of 16.76%. The firm earned $28.50 billion during the quarter. During the same quarter last year, the company earned $1.03 EPS. The firm’s revenue for the quarter was down 1.8% compared to the same quarter last year. On average, analysts expect that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 10th. Shareholders of record on Wednesday, February 15th will be given a dividend of $0.375 per share. The ex-dividend date of this dividend is Monday, February 13th. This represents a $1.50 dividend on an annualized basis and a yield of 1.80%. Walgreens Boots Alliance’s payout ratio is currently 39.68%.

WARNING: This story was posted by sleekmoney and is the sole property of of sleekmoney. If you are accessing this story on another domain, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be read at http://sleekmoney.com/walgreens-boots-alliance-inc-wba-stake-held-by-douglass-winthrop-advisors-llc/1655757.html.

A number of research analysts have issued reports on WBA shares. Leerink Swann set a $90.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Sunday, January 8th. Jefferies Group LLC set a $95.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Sunday, October 23rd. Deutsche Bank AG set a $92.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Saturday, January 21st. Atlantic Securities raised shares of Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and set a $95.00 price target for the company in a report on Monday, February 6th. Finally, Barclays PLC set a $79.00 price target on shares of Walgreens Boots Alliance and gave the stock a “hold” rating in a report on Friday, October 21st. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and twelve have given a buy rating to the stock. Walgreens Boots Alliance has an average rating of “Buy” and a consensus target price of $91.38.

In related news, COO Ornella Barra purchased 124,000 shares of the stock in a transaction dated Tuesday, February 7th. The shares were acquired at an average cost of $80.93 per share, with a total value of $10,035,320.00. Following the purchase, the chief operating officer now directly owns 1,690,336 shares in the company, valued at approximately $136,798,892.48. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Kathleen Wilson-Thompson sold 5,700 shares of the company’s stock in a transaction on Monday, November 28th. The stock was sold at an average price of $85.05, for a total transaction of $484,785.00. The disclosure for this sale can be found here. 13.50% of the stock is currently owned by corporate insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/walgreens-boots-alliance-inc-wba-stake-held-by-douglass-winthrop-advisors-llc/1655757.html

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *